Bal Pharma Ltd Annually Results

Gross Sales

303.08

339.22

304.22

281.21

250.53

Excise Duty

0

0

0

0

0

Net Sales

303.08

339.22

304.22

281.21

250.53

Other Operating Income

0

0

0

0

0

Other Income

2.2

2.85

0.98

5.15

1.14

Total Income

305.29

342.07

305.19

286.37

251.67

Total Expenditure

273.52

308.47

278.82

257.74

226.07

PBIDT

31.76

33.6

26.37

28.63

25.6

Interest

16.85

14.48

12.49

10.41

11.97

PBDT

14.91

19.12

13.88

18.22

13.62

Depreciation

9.77

10.07

9.13

9.04

9.52

Minority Interest Before NP

0

0

0

0

0

Tax

-0.14

0.76

2.03

5.42

-0.61

Deferred Tax

-1.96

0.85

0.1

-1.94

0

Reported Profit After Tax

7.24

7.45

2.62

5.7

4.71

Minority Interest After NP

0.02

0.05

0.05

0.09

-0.03

Net Profit after Minority Interest

7.22

7.39

2.57

5.61

4.74

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

7.22

7.39

2.57

5.61

4.74

EPS (Unit Curr.)

4.56

4.94

1.67

3.79

3.34

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

12

12

10

10

10

Equity

15.92

15.8

15.69

14.82

14.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.47

9.9

8.66

10.18

10.21

PBDTM(%)

4.91

5.63

4.56

6.47

5.43

PATM(%)

2.38

2.19

0.86

2.02

1.88